Literature DB >> 19538575

Expert review of the evidence base for prevention of travelers' diarrhea.

Herbert L DuPont1, Charles D Ericsson, Michael J G Farthing, Sherwood Gorbach, Larry K Pickering, Lars Rombo, Robert Steffen, Thomas Weinke.   

Abstract

The most frequent illness among persons traveling from developed to developing countries is travelers' diarrhea. Travelers to high-risk regions traditionally have been educated to exercise care in food and beverage selection. Innovative research is needed to identify ways to motivate people to exercise this care and to determine its value. Chemoprophylaxis can be recommended for certain groups while monitoring for safety, drug resistance, and efficacy against all forms of bacterial diarrhea. Research to evaluate the value of immunoprophylaxis is recommended. In the following document, the authors used an evidence base when available to determine strength and quality of evidence and when data were lacking, the panel experts provided consensus opinion.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19538575     DOI: 10.1111/j.1708-8305.2008.00299.x

Source DB:  PubMed          Journal:  J Travel Med        ISSN: 1195-1982            Impact factor:   8.490


  22 in total

1.  Inflammatory bowel disease in travelers: choosing the right vaccines and check-ups.

Authors:  Maria Esteve; Carme Loras; Ester García-Planella
Journal:  World J Gastroenterol       Date:  2011-06-14       Impact factor: 5.742

Review 2.  Traveler's Diarrhea.

Authors:  Stanley L Giddings; A Michal Stevens; Daniel T Leung
Journal:  Med Clin North Am       Date:  2016-03       Impact factor: 5.456

3.  Seasonality of diarrheagenic Escherichia coli pathotypes in the US students acquiring diarrhea in Mexico.

Authors:  Mercedes Paredes-Paredes; Pablo C Okhuysen; Jose Flores; Jamal A Mohamed; Ranjit S Padda; Alexei Gonzalez-Estrada; Clinton A Haley; Lily G Carlin; Parvathy Nair; Herbert L DuPont
Journal:  J Travel Med       Date:  2011-02-07       Impact factor: 8.490

Review 4.  Paediatric travel medicine: vaccines and medications.

Authors:  Mike Starr
Journal:  Br J Clin Pharmacol       Date:  2013-06       Impact factor: 4.335

5.  In vitro antimicrobial susceptibility of bacterial enteropathogens isolated from international travelers to Mexico, Guatemala, and India from 2006 to 2008.

Authors:  Jeannette Ouyang-Latimer; Syed Jafri; Audrey VanTassel; Zhi-Dong Jiang; Kaur Gurleen; Savio Rodriguez; Ranjan K Nandy; Thandavaryan Ramamurthy; Santanu Chatterjee; Robin McKenzie; Robert Steffen; Herbert L DuPont
Journal:  Antimicrob Agents Chemother       Date:  2010-11-29       Impact factor: 5.191

Review 6.  Recent advances in understanding enteric pathogenic Escherichia coli.

Authors:  Matthew A Croxen; Robyn J Law; Roland Scholz; Kristie M Keeney; Marta Wlodarska; B Brett Finlay
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

Review 7.  Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases.

Authors:  Hoonmo L Koo; Herbert L DuPont
Journal:  Curr Opin Gastroenterol       Date:  2010-01       Impact factor: 3.287

8.  ACG Clinical Guideline: Diagnosis, Treatment, and Prevention of Acute Diarrheal Infections in Adults.

Authors:  Mark S Riddle; Herbert L DuPont; Bradley A Connor
Journal:  Am J Gastroenterol       Date:  2016-04-12       Impact factor: 10.864

9.  2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea.

Authors:  Andi L Shane; Rajal K Mody; John A Crump; Phillip I Tarr; Theodore S Steiner; Karen Kotloff; Joanne M Langley; Christine Wanke; Cirle Alcantara Warren; Allen C Cheng; Joseph Cantey; Larry K Pickering
Journal:  Clin Infect Dis       Date:  2017-11-29       Impact factor: 9.079

10.  2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea.

Authors:  Andi L Shane; Rajal K Mody; John A Crump; Phillip I Tarr; Theodore S Steiner; Karen Kotloff; Joanne M Langley; Christine Wanke; Cirle Alcantara Warren; Allen C Cheng; Joseph Cantey; Larry K Pickering
Journal:  Clin Infect Dis       Date:  2017-11-29       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.